Research Analysts’ Updated EPS Estimates for November 10th (AAOI, ALDX, APN, AZN, BCAX, BYG, CLMT, CNH, COA, CTL)

Research Analysts’ updated eps estimates for Monday, November 10th:

Applied Optoelectronics (NASDAQ:AAOI) had its sell rating reaffirmed by analysts at B. Riley. The firm currently has a $15.00 price target on the stock.

Aldeyra Therapeutics (NASDAQ:ALDX) had its buy rating reissued by analysts at BTIG Research. They currently have a $9.00 price target on the stock.

APN Resources (LON:APN) had its hold rating reissued by analysts at Peel Hunt. They currently have a GBX 195 price target on the stock.

AstraZeneca (LON:AZN) had its buy rating reiterated by analysts at Jefferies Financial Group Inc.. They currently have a £150 target price on the stock.

AstraZeneca (LON:AZN) had its overweight rating reissued by analysts at JPMorgan Chase & Co..

Bicara Therapeutics (NASDAQ:BCAX) had its outperform rating reaffirmed by analysts at Wedbush. Wedbush currently has a $30.00 price target on the stock.

Big Yellow Group (LON:BYG) had its add rating reaffirmed by analysts at Peel Hunt. They currently have a GBX 1,310 target price on the stock.

Calumet (NASDAQ:CLMT) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $33.00 target price on the stock.

CNH Industrial (NYSE:CNH) had its buy rating reaffirmed by analysts at Truist Financial Corporation. Truist Financial Corporation currently has a $13.00 price target on the stock, down from their previous price target of $14.00.

Coats Group (LON:COA) had its buy rating reiterated by analysts at Berenberg Bank. They currently have a GBX 130 target price on the stock.

CleanTech Lithium (LON:CTL) had its speculative buy rating reiterated by analysts at Canaccord Genuity Group Inc.. They currently have a GBX 20 target price on the stock.

CubeSmart (NYSE:CUBE) had its sector weight rating reaffirmed by analysts at KeyCorp.

Cytokinetics (NASDAQ:CYTK) had its buy rating reaffirmed by analysts at B. Riley. They currently have a $90.00 target price on the stock, up from their previous target price of $80.00.

DraftKings (NASDAQ:DKNG) had its buy rating reissued by analysts at Stifel Nicolaus. Stifel Nicolaus currently has a $46.00 target price on the stock, down from their previous target price of $50.00.

DraftKings (NASDAQ:DKNG) had its buy rating reaffirmed by analysts at Needham & Company LLC. They currently have a $52.00 target price on the stock.

ECO Animal Health Group (LON:EAH) had its buy rating reiterated by analysts at Shore Capital. They currently have a GBX 150 price target on the stock.

Envela (NYSEAMERICAN:ELA) had its buy rating reaffirmed by analysts at B. Riley. They currently have a $14.00 target price on the stock, up from their previous target price of $11.00.

EnQuest (LON:ENQ) had its buy rating reaffirmed by analysts at Shore Capital. They currently have a GBX 28 price target on the stock.

EnQuest (LON:ENQ) had its buy rating reissued by analysts at Peel Hunt. They currently have a GBX 24 target price on the stock.

Eagle Eye Solutions Group (LON:EYE) had its house stock rating reiterated by analysts at Shore Capital.

Six Flags Entertainment (NYSE:FUN) had its equal weight rating reiterated by analysts at Morgan Stanley. Morgan Stanley currently has a $20.00 target price on the stock, down from their previous target price of $30.00.

Ferrexpo (LON:FXPO) had its hold rating reissued by analysts at Peel Hunt. They currently have a GBX 53 price target on the stock.

CGI Group (NYSE:GIB) (TSE:GIB.A) had its hold rating reiterated by analysts at Jefferies Financial Group Inc.. Jefferies Financial Group Inc. currently has a $81.00 target price on the stock, down from their previous target price of $105.00.

Harbour Energy (LON:HBR) had its buy rating reiterated by analysts at Canaccord Genuity Group Inc.. The firm currently has a GBX 282 price target on the stock.

HubSpot (NYSE:HUBS) had its neutral rating reissued by analysts at Rothschild & Co Redburn. Rothschild & Co Redburn currently has a $450.00 price target on the stock, down from their previous price target of $610.00.

International Consolidated Airlines Group (LON:IAG) had its outperform rating reissued by analysts at Royal Bank Of Canada. They currently have a GBX 500 price target on the stock.

CarMax (NYSE:KMX) had its equal weight rating reaffirmed by analysts at Morgan Stanley. They currently have a $35.00 price target on the stock, down from their previous price target of $56.00.

Kainos Group (LON:KNOS) had its add rating reissued by analysts at Peel Hunt. They currently have a GBX 1,100 price target on the stock.

Lantheus (NASDAQ:LNTH) had its hold rating reaffirmed by analysts at Truist Financial Corporation. Truist Financial Corporation currently has a $61.00 price target on the stock, down from their previous price target of $63.00.

MidCap Financial Investment (NASDAQ:MFIC) had its neutral rating reissued by analysts at Compass Point. They currently have a $12.25 target price on the stock, down from their previous target price of $14.75.

M&G (LON:MNG) had its sector perform rating reaffirmed by analysts at Royal Bank Of Canada. Royal Bank Of Canada currently has a GBX 265 target price on the stock.

Topgolf Callaway Brands (NYSE:MODG) had its neutral rating reiterated by analysts at B. Riley. B. Riley currently has a $11.00 price target on the stock, up from their previous price target of $9.50.

Nomad Foods (NYSE:NOMD) had its buy rating reiterated by analysts at BTIG Research. BTIG Research currently has a $18.00 price target on the stock.

Intellia Therapeutics (NASDAQ:NTLA) had its buy rating reiterated by analysts at Truist Financial Corporation. They currently have a $14.00 target price on the stock, down from their previous target price of $25.00.

Novavax (NASDAQ:NVAX) had its buy rating reaffirmed by analysts at B. Riley. The firm currently has a $16.00 target price on the stock, down from their previous target price of $18.00.

NVIDIA (NASDAQ:NVDA) had its buy rating reissued by analysts at UBS Group AG.

Navitas Semiconductor (NASDAQ:NVTS) had its neutral rating reiterated by analysts at Rosenblatt Securities. Rosenblatt Securities currently has a $8.00 target price on the stock.

Potlatch (NASDAQ:PCH) had its sector perform rating reissued by analysts at Royal Bank Of Canada. They currently have a $48.00 target price on the stock.

Vaxcyte (NASDAQ:PCVX) had its buy rating reiterated by analysts at BTIG Research. The firm currently has a $85.00 price target on the stock.

Parker-Hannifin (NYSE:PH) had its buy rating reiterated by analysts at Argus. The firm currently has a $900.00 price target on the stock.

Prime Medicine (NYSE:PRME) had its outperform rating reissued by analysts at Wedbush. The firm currently has a $8.00 target price on the stock.

Privia Health Group (NASDAQ:PRVA) had its buy rating reissued by analysts at Truist Financial Corporation. They currently have a $31.00 target price on the stock, up from their previous target price of $30.00.

Rainbow Rare Earths (LON:RBW) had its buy rating reiterated by analysts at Berenberg Bank. They currently have a GBX 33 price target on the stock.

RHI Magnesita (LON:RHIM) had its buy rating reaffirmed by analysts at Peel Hunt. The firm currently has a GBX 4,200 target price on the stock.

Sun Life Financial (NYSE:SLF) (TSE:SLF) had its sector perform rating reissued by analysts at Royal Bank Of Canada. The firm currently has a $84.00 price target on the stock.

SolGold (LON:SOLG) had its speculative buy rating reiterated by analysts at Canaccord Genuity Group Inc.. They currently have a GBX 46 target price on the stock.

Supermarket Income REIT (LON:SUPR) had its add rating reissued by analysts at Peel Hunt. They currently have a GBX 85 target price on the stock.

Tharisa (LON:THS) had its buy rating reiterated by analysts at Peel Hunt. Peel Hunt currently has a GBX 135 price target on the stock.

Treace Medical Concepts (NASDAQ:TMCI) had its hold rating reiterated by analysts at Truist Financial Corporation. The firm currently has a $4.00 target price on the stock, down from their previous target price of $7.00.

Tandem Diabetes Care (NASDAQ:TNDM) had its hold rating reiterated by analysts at Truist Financial Corporation. They currently have a $17.00 price target on the stock, up from their previous price target of $16.00.

Trex (NYSE:TREX) had its hold rating reaffirmed by analysts at Stifel Nicolaus. The firm currently has a $35.00 target price on the stock, down from their previous target price of $61.00.

Vericel (NASDAQ:VCEL) had its buy rating reaffirmed by analysts at Truist Financial Corporation. The firm currently has a $50.00 target price on the stock, up from their previous target price of $41.00.

YETI (NYSE:YETI) had its neutral rating reissued by analysts at B. Riley. The firm currently has a $35.00 target price on the stock, up from their previous target price of $32.00.